Responsible AI in Telehealth
Guidance for health systems adopting AI-assisted telehealth — safety, oversight, consent, and equity, from procurement to the point of care.
Summary
The bottom line for health-system leaders
Health systems do not need to become AI developers to adopt AI-assisted telehealth responsibly. They need a disciplined way to sort telehealth AI by clinical risk, an evidence standard that demands validation on their own patients before deployment, an oversight design that keeps a clinician meaningfully in charge rather than nominally in the loop, a consent and data-governance posture that treats patients as parties rather than data sources, and an explicit commitment that every deployment be examined for its effect on the populations least served by remote care. This brief supplies each of these as an instrument that can be lifted into local policy.
Guidance for health systems adopting AI-assisted telehealth — safety, oversight, consent, and equity, from procurement to the point of care.
Key findings
- Classify by clinical risk before you buy. Sort every candidate tool by how much it steers a clinical decision and how reversible its errors are. The tier—not the vendor's enthusiasm—sets the evidentiary and oversight bar for everything that follows.
- Validate on your own patients. A model's published accuracy describes the population it was tested on. Require local validation on a representative sample of your patients, disaggregated by the groups you serve, before a tool touches a live encounter.
How to cite this report
Responsible AI in Telehealth. FAIR Labs Policy Brief. Fair Artificial Intelligence Research Labs, 2025. Available at https://fairlabs.ai/research/responsible-ai-telehealth
FAIR Labs (Fair Artificial Intelligence Research Labs) is a nonpartisan 501(c)(3) research institute in Washington, DC. Its reports may be reproduced with attribution for non-commercial purposes. For interviews, briefings or data requests, use the contact form.